In summary, circMMP11 shows promise as a diagnostic biomarker target and a valuable therapeutic target for HCC as it plays an anti-tumor role by suppressing proliferation, migration, and invasion in HCC, possibly through the miR-361-3p/HMGB1 axis. This evidence concerns the gene HMGB1 and hepatocellular carcinoma.